News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

$4.2 Billion Deal Gives ViroPharma Incorporated (VPHM) Execs Huge Paydays



2/7/2014 6:48:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Shire’s $4.2 billion acquisition of ViroPharma last month generated a huge payday for ViroPharma’s top executives and board members. Documents filed with the Securities & Exchange Commission show the Exton, Pa., biopharmaceutical company’s top executive officers and seven board members held stock, vested and unvested options and performance share units valued at more than $260 million. In fact, it's uncertain which executives stayed with the merged company, as a Shire spokesperson declined commenting on that.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES